Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01409278 · ClinicalTrials.gov registry record · NA

Local Anesthetic Infiltration and Infusion for Pain Control After Hip Replacement

A NA study, sponsored by Trinity Health Of New England.

Completed
Registry status
NA
Development phase
105
Enrollment target

NCT01409278 is a NA study that has completed, run by Trinity Health Of New England. The registered enrollment target is 105 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01409278, a NA study, has completed, sponsored by Trinity Health Of New England.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target

Study Summary

The purpose of this study is to examine three different ways to control pain after hip replacement: 1. One time injection of ropivacaine before wound closure 2. One time injection of ropivacaine before wound closure plus slow release of ropivacaine via catheter for 48 hours 3. Standard practice of patient controlled pump

Interventions

  • PROCEDURE Normal Saline
  • PROCEDURE Ropivacaine infiltration and saline infusion.
  • PROCEDURE Ropivacaine infiltration and infusion.

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2009-08
Est. Completion 2011-06
Phase NA

Sponsor

Trinity Health Of New England

20 total trials

What the Registry Record Tells You About NCT01409278

The ClinicalTrials.gov registry entry for NCT01409278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.

NCT01409278 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01409278 about?

NCT01409278 is a clinical study titled "Local Anesthetic Infiltration and Infusion for Pain Control After Hip Replacement". The purpose of this study is to examine three different ways to control pain after hip replacement: 1. One time injection of ropivacaine before wound closure 2. One time injection of ropivacaine before wound closure plus slow release of ropivacaine via catheter for 48 hours 3. Standard practice of ...

What is the current status of trial NCT01409278?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2009-08. Estimated completion is 2011-06.

What interventions are being tested in trial NCT01409278?

The interventions under investigation include: Normal Saline (PROCEDURE), Ropivacaine infiltration and saline infusion. (PROCEDURE), Ropivacaine infiltration and infusion. (PROCEDURE).

Who is sponsoring clinical trial NCT01409278?

This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.